InvestSMART

Cellmid Limited (ASX: CDY) - Announcements

- Current share price for CDY : $0.056

ASX company news and announcements for Cellmid Limited (CDY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cellmid Limited (CDY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cellmid Limited (CDY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cellmid Limited (CDY)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
- Change of Director's Interest Notice-Eck 13 Sep 2018 9:33AM $0.400 $0.056 fallen by 86%
- Change of Director's Interest Notice-Gordon 13 Sep 2018 9:30AM $0.400 $0.056 fallen by 86%
- Change of Director's Interest Notice-Halasz 13 Sep 2018 9:27AM $0.400 $0.056 fallen by 86%
- Cleansing Notice 12 Sep 2018 11:19AM $0.390 $0.056 fallen by 85.64%
- Appendix 3B 12 Sep 2018 11:11AM $0.390 $0.056 fallen by 85.64%
- Lead Antibody Effective in Rare Chronic Kidney Disease 12 Sep 2018 10:08AM $0.380 $0.056 fallen by 85.26%
- Results of Meeting 7 Sep 2018 4:57PM $0.395 $0.056 fallen by 85.82%
- EGM Presentation by CEO 7 Sep 2018 10:18AM $0.380 $0.056 fallen by 85.26%
- Company Secretary Appointment/Resignation 6 Sep 2018 3:32PM $0.380 $0.056 fallen by 85.26%
- Cellmid Share Purchase Plan Completion 3 Sep 2018 9:34AM $0.390 $0.056 fallen by 85.64%
- Evolis USA Distribution Update 30 Aug 2018 9:46AM $0.375 $0.056 fallen by 85.07%
- Preliminary Final Report 24 Aug 2018 2:45PM $0.380 $0.056 fallen by 85.26%
- Cellmid Notice of Meeting 6 Aug 2018 12:16PM $0.405 $0.056 fallen by 86.17%
- Cleansing Notice and Appendix 3B 6 Aug 2018 9:45AM $0.405 $0.056 fallen by 86.17%
- Cellmid Share Purchase Plan 31 Jul 2018 11:33AM $0.405 $0.056 fallen by 86.17%
- Cellmid Share Placement Raises $9M 31 Jul 2018 9:42AM $0.460 $0.056 fallen by 87.83%
- Appendix 4C and Notes to Appendix 4C 31 Jul 2018 9:36AM $0.460 $0.056 fallen by 87.83%
- Trading Halt 27 Jul 2018 8:55AM $0.460 $0.056 fallen by 87.83%
- CELLMID UPDATES ON DISTRIBUTION OF EVOLIS 11 Jul 2018 8:40AM $0.435 $0.056 fallen by 87.13%
- CELLMID INVESTOR PRESENTATION 2 Jul 2018 12:25PM n/a $0.056 n/a
- MIDKINE SYMPOSIUM MUNICH 30 May 2018 9:37AM $0.515 $0.056 fallen by 89.13%
- CHANGE OF ADDRESS 29 May 2018 4:46PM $0.515 $0.056 fallen by 89.13%
- CELLMID TO COMMENCE SELLING OF EVOLIS INTO CHINESE MARKET 2 May 2018 10:21AM $0.510 $0.056 fallen by 89.02%
- CELLMID SECURES BLOOMINGDALES USA PARTNERSHIP FOR EVOLIS 24 Apr 2018 9:28AM $0.470 $0.056 fallen by 88.09%
- Appendix 4C - quarterly 23 Apr 2018 9:04AM $0.465 $0.056 fallen by 87.96%

226 - 250 of 530 results

Page 10 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.